0001140361-18-024278.txt : 20180516
0001140361-18-024278.hdr.sgml : 20180516
20180516183019
ACCESSION NUMBER: 0001140361-18-024278
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180514
FILED AS OF DATE: 20180516
DATE AS OF CHANGE: 20180516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES
CENTRAL INDEX KEY: 0001221590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 18841311
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2018-05-14
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001221590
BIENAIME JEAN JACQUES
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
1
1
0
0
Chief Executive Officer
Common Stock
2018-05-14
2018-05-14
4
M
0
18750
38.590
A
309350
D
Common Stock
2018-05-14
2018-05-14
4
S
0
18750
89.2187
D
290600
D
Common Stock
2018-05-15
2018-05-15
4
M
0
18750
38.590
A
309350
D
Common Stock
2018-05-15
2018-05-15
4
S
0
18750
88.2898
D
290600
D
Common Stock
182201
I
Shares held by Jean-Jacques Bienaime Family Trust
Stock Option (Right to buy Common Stock)
38.59
2018-05-14
2018-05-14
4
M
0
18750
0
D
2008-11-22
2018-05-21
Common Stock
18750
56250
D
Stock Option (Right to buy Common Stock)
38.59
2018-05-15
2018-05-15
4
M
0
18750
0
D
2008-11-22
2018-05-21
Common Stock
18750
37500
D
Trade made pursuant to a 10b5-1 plan executed on November 14, 2017.
The price in column 4 is the weighted average price. The price actually received ranged from $88.406 to $89.84. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
The price in column 4 is the weighted average price. The price actually received ranged from $87.65 to $88.70. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Laura Randall Woodhead, Attorney-in-Fact
2018-05-16